Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celgene Corp Issues FY 2017 EPS Guidance; Revenue Guidance Above Analysts' Estimates-Conference Call


Tuesday, 26 Feb 2013 03:00pm EST 

Celgene Corp announced that for fiscal 2017, it expects roughly $12 billion in top-line revenue and $13 to $14 a share of EPS. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $11.5 billion and EPS of $13.2 for fiscal 2017. 

Company Quote

117.18
0.7 +0.60%
19 Dec 2014